157 results on '"Pearson-Stuttard J"'
Search Results
2. EPH244 Late-Stage Cancer Diagnosis and Systemic Therapy in England Since 2018
3. EE453 Projecting the Economic Benefits of the Elective Recovery Plan in England
4. EPH24 Changes in Prescribing of Systemic Cancer Therapies in England: A Nationwide Analysis of Community and Hospital Medicines Utilisation
5. EPH56 The Impact of the COVID-19 Pandemic on Cardiovascular Disease Prevention and Corresponding Geographical Inequalities in England: Interrupted Time Series Analysis
6. QUANTIFYING THE POTENTIAL US HEALTH AND ECONOMIC EFFECTS OF THE FDA VOLUNTARY SALT REFORMULATION PROPOSAL
7. COMPARING THE IMPACT OF PRICE CHANGE AND MASS MEDIA CAMPAIGNS ON REDUCING CARDIOVASCULAR DISEASE MORTALITY AND DISPARITIES IN THE US
8. SYSTEMATIC REVIEW OF DIETARY TRANS-FAT REDUCTION POLICIES : EVIDENCE FOR AN EFFECTIVENESS HIERARCHY?
9. CO143 Project Ideate: Creating a Novel Linked Real World Data Environment in Wales for Use in an Experimental, Retrospective Outcome-Based Agreement of a Breast Cancer Treatment
10. HTA9 The Benefits That a Novel Antimicrobial Provides When Viewed From an Insurance Value Perspective
11. CO108 Project Ideate: Designing a Robust Methodology for an Experimental, Retrospective Outcome-Based Agreement in a Breast Cancer Treatment
12. EPH203 Estimating the Impact of COVID-19 Pandemic on Gynaecology Treatment in England
13. CO35 Project Ideate: Modelling Payments and Volatility of an Experimental, Retrospective Outcome-Based Agreement for a Breast Cancer Treatment in Wales, 2018-2020
14. EE357 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration and Impacts on Health Care Resource Usage: A Population Based Analysis of Real World Evidence
15. EPH57 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration: A Population Based Analysis of Real World Evidence
16. HPR58 Identifying Geographically Clustered Health Inequalities in England
17. HSD98 Estimating the Impact of the COVID-19 Pandemic on Healthcare Waiting Lists in England
18. IDF21-0404 Variations in comorbidity burden in patients with type 2 diabetes and impacts on healthcare resource usage and costs
19. OP95 Quantifying the potential us health and economic effects of the fda voluntary salt reformulation proposal
20. Lessons learned and lessons missed: impact of the coronavirus disease 2019 (COVID-19) pandemic on all-cause mortality in 40 industrialised countries and US states prior to mass vaccination [version 2; peer review: 2 approved]
21. Tackling health inequalities through the development of the wider public health workforce.
22. Life expectancy and risk of death in 6,791 English communities from 2002 to 2019: high-resolution spatiotemporal analysis of civil registration data
23. Characterising multimorbidity from type-2 diabetes: insights from clustering approaches
24. Trends in predominant causes of death in those with and without diabetes in England from 2001 to 2018
25. QUANTIFYING THE HEALTH AND ECONOMIC BENEFITS OF THE BRAZILIAN VOLUNTARY SALT REFORMULATION TARGETS: AN IMPACT(NCD BR) MICROSIMULATION
26. The Healthy Start scheme and its association with food expenditure in low-income families in the UK
27. OP32 Quantifying the health and economic benefits of the Brazilian voluntary salt reformulation targets: an IMPACTNCD BR microsimulation
28. Impacts of post-Brexit agricultural policy on fruit and vegetable intake and cardiovascular disease
29. Association Between Soft Drink Consumption and Mortality in 10 European Countries
30. IMPACT OF THE PUBLIC HEALTH RESPONSIBILITY DEAL ON SALT INTAKE, CARDIOVASCULAR DISEASE AND GASTRIC CANCER: INTERRUPTED TIME SERIES AND MICROSIMULATION STUDY
31. Soft drinks consumption and mortality in 10 European countries: a multinational cohort study
32. Association between Soft Drink Consumption and Mortality in 10 European Countries
33. Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: population-based analysis of vital registration data
34. Implications of Brexit on the effectiveness of the UK soft drinks industry levy upon coronary heart disease in England: a modelling study
35. OP10 Impact of the public health responsibility deal on salt intake, cardiovascular disease and gastric cancer: interrupted time series and microsimulation study
36. OP09 Impacts of post-brexit agricultural policy on fruit and vegetable intake and cardiovascular disease in england: a modelling analysis
37. OP19 Will social care need more resources? A modelling study of health and social costs in england and wales for alternative future cardiovascular disease scenarios
38. OP45 The potential impact of diabetes prevention on the future UK burden of dementia and disability
39. OP3 Cost-effectiveness of the U.S. FDA added sugar labeling policy for improving cardiometabolic health: microsimulation modelling study
40. OP1 Cost-effectiveness of the FDA salt reduction targets for the processed food industry: are there internal incentives to reformulate?
41. OP42 Potential impacts of brexit on cardiovascular disease via changes to the price of fruits and vegetables: a modelling analysis
42. OP73 Systematic review of dietary trans-fat reduction policies: evidence for an effectiveness hierarchy?
43. Large-scale unselected community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people
44. OP95 Quantifying the potential us health and economic effects of the fda voluntary salt reformulation proposal
45. OP73 Systematic review of dietary trans-fat reduction policies: evidence for an effectiveness hierarchy?
46. OP83 Comparing the impact of price change and mass media campaigns on reducing cardiovascular disease mortality and disparities in the US
47. OP03 Predicting cardiovascular disease mortality rates in the united states in 2030: prospective modelling approaches
48. OP51 Comparing the effectiveness of price reduction and mass media campaigns in reducing cvd mortality by targeting fruit and vegetables intake
49. PL01 Exploring the potential of trans fats policies to reduce socio-economic inequalities in cardiovascular disease mortality in england: a cost-effectiveness modelling study
50. OP57 Cost effectiveness analysis of a UK legislative ban on dietary industrial trans fats: modelling study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.